Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block

Cesarean Delivery Clinical Trial

Official title:

Comparison of Efficacy and Side Effects of Intrathecal Morphine and TAP Block for Post-cesarean Analgesia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00799955
• Other study ID #: H08-01726
• Status: Completed
• Phase: N/A
• First received: November 26, 2008
• Last updated: January 22, 2013
• Start date: October 2008
• Est. completion date: April 2010

Study information

• Verified date: January 2013
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

Summary Brief Summary Standard care for pain relief after cesarean delivery is spinal morphine. Spinal morphine may be unsuitable for patients having general anesthetic or prior morphine-related side effects and can be less effective in patients with morphine tolerance. An alternative is a TAP block where local anesthetic is deposited between the abdominal muscles consequently numbing the area and providing pain relief. The investigators believe a TAP block will provide equivalent pain relief to spinal morphine.

Description:

Detailed Description In North America, the standard of care is neuraxial morphine. This is an effective analgesic, but can still cause problems with nausea, vomiting and itching. Spinal morphine may be unsuitable for patients who have had morphine-related side effects in the past and can be less effective in patients with morphine tolerance. It is also poorly suited for patients who have had a general anesthetic, as anesthesiologists do not routinely access the spinal space purely for analgesia. It is only when they are using the spinal route for surgical anesthesia, that they will also deposit morphine to provide pain relief after surgery.

The abdominal wall incision is an important contributor to pain following a cesarean delivery. The nerves supplying the anterior abdominal wall between the internal oblique and transversus abdominis muscles. By depositing local anesthetic solution between these muscles on each side, it is possible to block all these nerves and provide analgesia for the incision of the anterior abdominal wall. This is known as the transversus abdominis plane block or TAP block.

Studies have shown the TAP block to be useful for midline laparotomies for open prostatectomies, bowel resection and as rescue analgesia for abdominal surgery. There are two studies which look specifically at TAP block after cesarean delivery but none of them have compared it directly the current standard.

This study is a direct comparison of spinal morphine and TAP block. Obviously, adequate analgesia is of paramount importance to the patient and those caring for her. Studies to date indicate that the TAP block provides similar analgesia to spinal morphine in the early post-operative period. Therefore it would be a reasonable alternative for those patients who cannot have spinal morphine or who can not tolerate spinal morphine due to its side effects.

The primary objective will be to investigate whether the tranversus abdominis plane block provides equivalent analgesia post-cesarean delivery, as intrathecal morphine.

The secondary objective will be to determine whether there is a difference in post-operative abdominal scar pain, at three months post-surgery.

This study will be a prospective, randomized, placebo-controlled, double blinded study.

The study will involve two groups. Both groups will have spinal anesthesia for the surgery provided with 9-12 mg heavy bupivacaine and 10 mcg fentanyl.

1. Control group: standard care plus a placebo block.

2. Intervention group: no additional spinal medications will be given and an ultrasound-guided TAP Block will be given instead of the standard intrathecal morphine.

Standard post-cesarean analgesia and PONV orders will be resumed post-delivery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: April 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 19 Years to 45 Years

Eligibility

Inclusion Criteria:

• Elective cesarean delivery under spinal anesthesia patients.

• >28 weeks gestation

• ASA 1 and 2 classification of health

• Mothers presenting to the assessment unit with ruptured membranes or in early stages of labour for whom a vaginal birth was not planned and who are therefore in need of urgent cesarean delivery.

• Able to read and understand English,

• Only patients expected to deliver before midday will be approached for participation in the trial to facilitate post-operative data collection.

Exclusion Criteria:

• Mothers in active labour

• ASA classification 3 or above

• Emergency cesarean delivery for fetal heart rate abnormalities

• Cesarean delivery under general anesthesia

• Maternal age <19

• BMI >40.

• Cesarean deliveries where a CSE is planned.

• Mothers with a history of drug allergy to morphine or to local anesthetics

• Mothers who are likely to deviate from standard postpartum analgesia protocol because of history of morphine tolerance or sensitivity.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Cesarean Delivery

Intervention

Procedure:
• Placebo block
100 micrograms of spinal morphine
• Ultrasound-guided TAP block
1.5mg/kg of 0. 5% ropivacaine (to maximum dose of 20 mls = 100mg on each side) will be injected into the transversus abdominis plane, on each side

Locations

Country	Name	City	State
Canada	BC Women's Hospital Dept of Anesthesia	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Morphine equivalents used in the 24h post-delivery		24 hours post operation	No
Secondary	Pain scores at rest, and with movement as assessed by verbal analogue score on arrival to recovery and at 2, 6, 10, and 24h post-spinal drug administration; post-operative nausea and vomiting scores, sedation score, presence or absence of itch; presence		3 months	No